The increasing adoption of digital technologies has significantly expanded the volume and diversity of data generated across clinical development. Sponsors and contract research organizations now operate complex technology ecosystems comprising clinical trial management systems, electronic data capture platforms, electronic health records, laboratory systems, decentralized trial technologies, and real-world data sources. While these investments have strengthened digital capabilities, many organizations continue to face challenges in achieving seamless interoperability across their clinical landscape.
The operational challenges include duplicate data entry, fragmented workflows, manual reconciliation, delayed reporting, and inconsistent visibility across studies. These inefficiencies can affect study timelines, increase operational costs, and create additional compliance risks, particularly as organizations manage increasingly complex global clinical programs.
Clinical trial interoperability has therefore evolved beyond a technology integration initiative. It has become an operational priority that influences study execution, data quality, regulatory readiness, and decision-making across the clinical development lifecycle. As organizations seek to modernize their clinical platforms, engineering delivery models are also evolving to support closer alignment between technology implementation and business outcomes.
Forward Deployed Engineering is emerging as one such delivery model. By embedding engineering teams alongside clinical, operational, and technology stakeholders, it enables organizations to design, build, and optimize solutions within the context of real-world clinical operations. This collaborative approach helps bridge the gap between platform modernization and operational excellence.
Forward Deployed Engineering as a Delivery Model
Forward Deployed Engineering represents a collaborative engineering approach in which multidisciplinary teams work directly with business and operational stakeholders throughout solution design, implementation, and optimization.
Within healthcare and life sciences, this model brings together engineering, interoperability specialists, clinical operations, regulatory affairs, data management, quality, and enterprise technology teams to address business challenges collectively rather than sequentially.
This approach enables engineering decisions to be informed by operational realities, helping organizations develop solutions that align more closely with study execution, compliance requirements, and long-term platform strategies.
A Practical Forward Deployed Engineering Process for Interoperability
A structured Forward Deployed Engineering process turns interoperability from a broad technology ambition into a sequence of testable operational decisions. The process begins with customer context, exposes the real workflow and data barriers, and then narrows the work into a measurable pilot that can be validated and scaled, taking into consideration the following:
- Defining the outcome. Translate the request for an interface, dashboard, or automation into a business outcome: who benefits, which clinical workflow improves, and what better performance looks like.
- Establishing “why” now. Identify the event, deadline, or risk creating urgency, such as a study launch, platform migration, regulatory commitment, data-quality issue, or recurring operational delay.
- Setting the success metric. Document the current baseline, target state, measurement source, and review point—for example, fewer manual reconciliations, faster data availability, or improved issue-resolution time.
- Surfacing constraints. Record security, privacy, validation, regulatory, architectural, data-residency, timeline, and resourcing constraints, together with a customer-side owner for each one.
- Mapping systems of record. For every critical data need, identify the authoritative source, data owner, access method, expected freshness, standards or terminology, and downstream consumers. This creates the factual basis for the interoperability design.
- Aligning stakeholders and decision rights. Name the buyer, clinical or operational owner, technical owner, champion, quality and regulatory partners, and likely blockers so that decisions and escalations have clear ownership.
- Separating the stated request from the real blocker. Validate the request against observed workflows, user interviews, and data evidence. A request for a chatbot or new integration may actually reveal missing master data, unclear ownership, or a broken handoff between systems.
- Defining and executing the pilot. Agree on what is in scope and out of scope, the representative workflow and dataset, acceptance measures, go/no-go criteria, and the path to production. The embedded team then builds alongside users, tests the solution in context, captures reusable integration patterns, and transfers operational ownership before scaling.
This process keeps interoperability work anchored in clinical value while creating the technical, governance, and adoption evidence required for responsible scale.
Enabling Clinical Trial Interoperability Through Forward Deployed Engineering
Forward Deployed Engineering supports interoperability initiatives in several ways:
- First, it enables engineering teams to develop a deeper understanding of clinical workflows before designing integrations or platform enhancements. This helps ensure that interoperability initiatives support operational objectives rather than simply connecting systems.
- Second, embedded engineering teams can accelerate modernization by designing scalable integration architectures that accommodate both legacy applications and modern cloud platforms. Standards-based application programming interfaces, event-driven architectures, and reusable integration components can improve data exchange while reducing implementation complexity.
- Third, as organizations expand the use of artificial intelligence (AI), interoperable data environments become increasingly important. High-quality, connected datasets provide the foundation for advanced analytics, intelligent automation, AI-assisted clinical workflows, and emerging agentic AI capabilities.
- Finally, regulatory and quality considerations can be incorporated throughout the engineering lifecycle. Auditability, data lineage, validation planning, security controls, and governance mechanisms can be addressed as part of solution design rather than being introduced during later project phases.
Conclusion
Clinical trial interoperability has become a strategic capability for organizations seeking to improve study execution, accelerate decision-making, and enable AI-driven innovation. Achieving these objectives requires more than modern technology platforms; it also depends on engineering models that integrate technical expertise with operational knowledge.
Forward Deployed Engineering provides a collaborative framework for aligning platform modernization with clinical and business priorities. By embedding engineering teams within customer environments, organizations can improve interoperability, strengthen adoption, and build digital capabilities that support long-term operational excellence.
Contributed by Ram Sathia, Founder and CEO of Infiligence, and edited by Gary Cramer at ACRP. Sathia is a technology leader with more than 25 years of experience in AI-driven automation, DevOps, and enterprise architecture. At Infiligence, he helps organizations build intelligent, self-sustaining engineering ecosystems. He has led large-scale digital transformation initiatives for Fortune 100 companies and holds multiple patents in automation and intelligent systems.
